4//SEC Filing
Umstead John V. 4
Accession 0001562180-23-002913
CIK 0001560241other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:20 PM ET
Size
11.4 KB
Accession
0001562180-23-002913
Insider Transaction Report
Form 4
Umstead John V.
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-15+50,000→ 58,886 total - Award
Stock Options (Right to Buy)
2023-03-15+100,000→ 100,000 totalExercise: $3.27Exp: 2033-03-15→ Common Stock (100,000 underlying)
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award that vests 25% on March 15, 2024 and 25% annually thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 2,036 shares of common stock; (ii) 850 RSUs from award granted on January 4, 2021; (iii) 3,000 RSUs from award granted on January 3, 2022; (iv) 3,000 RSUs from award granted on January 3, 2023; and (v) 50,000 RSUs from award granted on March 15, 2023.
- [F4]The shares underlying this option vest as to 25% of the shares on March 15, 2024, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001967910
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:20 PM ET
- Size
- 11.4 KB